ReviewPaediatric drugs2023

Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab.

Yoni E van Dijk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.